Recalling firm
RemedyRePack Inc.
Product type
Drug
Status
Ongoing
Report date
2025-05-14
Distribution
Within U.S - PA, VA, FL.
Firm state
PA
Product quantity
23 bottles/30 count- 690 capsules
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPAReason for recall
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Product description
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
Code / lot info
Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
Other recalls SPEQ maps to Risk Management & CAPA
See all Risk Management & CAPA recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.